CRISPR Therapeutics Names Andrew J. Silver CFO as Raju Prasad Resigns
Andrew J. Silver’s appointment as chief financial officer is effective October 19, 2026. Raju Prasad resigned to pursue external opportunities.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.